Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 8.56% is in line with its 5-year average of 8.95%, near the low end of its 5-year range (5.69%–17.65%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.05% below its 12-month average of 10.45%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.56%.
DEBT TO ASSETS RATIO
8.56%
DEBT TO ASSETS RATIO AVG TTM
10.45%
DEBT TO ASSETS RATIO AVG 3Y
9.86%
DEBT TO ASSETS RATIO AVG 5Y
8.95%
DEBT TO ASSETS RATIO AVG 10Y
6.15%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-18.05%
CURRENT VS 3Y AVG
-13.17%
CURRENT VS 5Y AVG
-4.32%
CURRENT VS 10Y AVG
+39.15%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+2905.01%
vs the sector median at left
Intellia Therapeutics, Inc.
Market Cap
$1.72B
Debt to Assets Ratio
8.56%
TTM Avg
10.45%
3Y Avg
9.86%
5Y Avg
8.95%
Market Cap
$1.73B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.14B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$999.26M
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.51B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.73B
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$397.55M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | $1.72B | 8.56% | 10.45% | 9.86% | 8.95% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 0.44% | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | 0.05% | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $999.26M | 0.38% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.51B | 0.18% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.73B | 0.59% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $473.82M | 0.33% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $459.30M | 0.66% | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | 0.10% | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.30M | 0.50% | N/A | N/A | N/A |
Debt/Assets
8.6%
Debt/Equity
0.10
Current Ratio
6.65
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 8.56% |
| 2026-03-31 | 10.61% |
| 2025-12-31 | 11.08% |
| 2025-09-30 | 10.59% |
| 2025-06-30 | 11.41% |
| 2025-03-31 | 12.09% |
| 2024-12-31 | 17.65% |
| 2024-09-30 | 8.66% |
| 2024-06-30 | 8.92% |
| 2024-03-31 | 8.80% |
| 2023-12-31 | 8.87% |
| 2023-09-30 | 9.52% |
| 2023-06-30 | 9.24% |
| 2023-03-31 | 8.90% |
| 2022-12-31 | 8.60% |
| 2022-09-30 | 9.00% |
| 2022-06-30 | 6.26% |
| 2022-03-31 | 5.97% |
| 2021-12-31 | 5.72% |
| 2021-09-30 | 5.69% |
| 2021-06-30 | 10.51% |
| 2021-03-31 | 10.15% |
| 2020-12-31 | 5.81% |
| 2020-09-30 | 4.84% |
| 2020-06-30 | 4.72% |
| 2020-03-31 | 7.74% |
| 2019-12-31 | 5.50% |
| 2019-09-30 | 5.67% |
| 2019-06-30 | 5.58% |
| 2019-03-31 | 5.67% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2014-12-31 | 0.00% |
